annual meeting program - American Society of Clinical Oncology

SATURDAY
Saturday, June 5, 2010
Discussion
3:00 PM Joachim Yahalom, MD (Abstracts #8008–8009)
Memorial Sloan-Kettering Cancer Center
What Is the Role of Radiation in Large Cell Lymphoma?
3:15 PM A phase I study of IV aflibercept (Afl) in combination with R-CHOP in
untreated patients (pts) with B-cell lymphoma. (Abstract #8010)
F. Kuhnowski, C. Thieblemont, F. Jardin, F. Broussais-Guillemot, M. Meignan,
J. Cabecadas, P. Gaulard, H. Tilly, C. Oprea, C. Haioun
3:30 PM Rituximab plus gemcitabine and oxaliplatine (R-GemOx) in
refractory/relapsed patients with diffuse large B-cell lymphoma (DLBCL) who
are not candidates for high-dose therapy (HDT): A GELA study. (Abstract
#8011)
T. EL Gnaoui, H. Tilly, N. Mounier, C. Gisselbrecht, C. Sebban, O. Casasnovas,
R. Delarue, T. Petrella, D. Canioni, C. Haioun
3:45 PM Effect of Btk inhibitor PCI-32765 monotherapy on responses in patients with
relapsed aggressive NHL: Evidence of antitumor activity from a phase I
study. (Abstract #8012)
R. Advani, J. P. Sharman, S. M. Smith, D. A. Pollyea, T. E. Boyd, B. W. Grant,
K. S. Kolibaba, J. J. Buggy, A. Hamdy, N. H. Fowler
132